Unihealth Hospitals Ltd Stock Price Today (NSE: UNIHEALTH)

Unihealth Hospitals Ltd

UNIHEALTHHospital
720.004.95 (0.68%)
Market Open

Fundamental Score

...

Unihealth Hospitals Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Unihealth Hospitals Ltd share price today is 720.00, down 0.68% on NSE/BSE as of 2 September 2026. Unihealth Hospitals Ltd (UNIHEALTH) is a Small-cap company in the Hospital sector with a market capitalisation of 1.12K (Cr). The 52-week high for UNIHEALTH share price is 820.00 and the 52-week low is 133.65. At a P/E ratio of 43.83x, UNIHEALTH is currently trading below its industry average P/E of 48.79x. The company has a Return on Equity (ROE) of 21.46% and a debt-to-equity ratio of 0.24.

Unihealth Hospitals Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
820.00
Low
653.00
Volume
23.7K
Change
+0.36%

Unihealth Hospitals Ltd share price chart: 0.36% return over the past month. 52-week high ₹820.00, 52-week low ₹133.65.

Unihealth Hospitals Ltd — Last 10 Trading Days

DateOpenHighLowCloseVolume
717.95718.00695.00707.1519.50K (Cr)
706.45712.95691.15707.509.00K (Cr)
717.10717.10697.05705.5520.50K (Cr)
735.00738.00700.00719.6021.00K (Cr)
700.10700.10653.00676.1551.00K (Cr)
715.00727.00698.00702.707.00K (Cr)
702.00718.00702.00715.0018.00K (Cr)
754.00754.00695.00719.9543.00K (Cr)
773.00779.00754.25756.758.00K (Cr)
760.00774.00760.00774.005.50K (Cr)

Unihealth Hospitals Ltd — Last 12 Months Price History

MonthOpenHighLowCloseChange
735.00820.00653.00707.15-3.79%
613.25819.95598.00750.00+22.30%
409.70629.50378.35628.45+53.39%
504.50504.50400.00431.20-14.53%
380.00529.80362.20480.50+26.45%
315.00410.00312.50362.40+15.05%
290.00347.15285.00327.10+12.79%
293.00327.00255.00289.00-1.37%
319.00349.85262.20299.10-6.24%
158.00390.60153.55335.75+112.50%
159.00173.70155.00168.00+5.66%
161.00177.80133.65161.50+0.31%

Returns & Performance

Excellent

Return on Equity (ROE)

21.46%

Profit generated per ₹1 of shareholder equity

Excellent

Return on Capital (ROCE)

24.48%

Returns generated on total capital deployed

Excellent

Oper. Profit Margin (5Y Avg)

37.05%

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Unihealth Hospitals Ltd Valuation Check

Good

Price to Earnings (P/E)

43.83x

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

48.79x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Excellent

Promoter Holding

69.53%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.48%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Good

Profit Growth (Quarterly YoY)

18.98%

Net profit growth vs same quarter last year

Good

Revenue Growth (Quarterly YoY)

17.06%

Revenue growth vs same quarter last year

Excellent

Revenue Growth (5-Year CAGR)

38.17%

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Excellent

Net Profit Growth (5-Year CAGR)

38.61%

Compounded annual net profit growth over 5 years

Balance Sheet Health

Excellent

Debt to Equity Ratio

0.24x

Total debt ÷ equity. Below 0.5 = financially healthy

Excellent

Interest Coverage Ratio

20.65x

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-28.85 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Unihealth Hospitals Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of UNIHEALTH across key market metrics for learning purposes.

Positive Indicators

11 factors identified

Strong Return on Equity (21.46%)

Observation: Efficient use of shareholders' capital generating superior returns.

Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.

Excellent ROCE Performance (24.48%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Strong Operating Margins (37.05%)

Observation: Healthy 5-year operating margins indicate pricing power and cost control.

Analysis: OPM >15% suggests operational efficiency and competitive advantages.

Strong Revenue Growth (17.06%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Consistent Growth Track Record (38.17% CAGR)

Observation: Strong 5-year sales compound annual growth rate.

Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.

Strong Profit Growth Track Record (38.61% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Conservative Debt Levels (D/E: 0.24)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (20.65x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Healthy Liquidity Position (Current Ratio: 5.87)

Observation: Strong short-term liquidity to meet obligations.

Analysis: Current ratio >1.5 indicates good working capital management.

Balanced Promoter Holding (69.53%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

5 factors identified

Premium Valuation Risk (P/E: 43.83x)

Observation: High valuation multiples may limit upside potential.

Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.

High Price-to-Book Ratio (12.98x)

Observation: Trading at significant premium to book value.

Analysis: High P/B ratios may indicate overvaluation relative to asset base.

Negative Free Cash Flow (₹-28.85 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Limited Institutional Interest (FII+DII: 0.48%)

Observation: Low institutional participation may affect liquidity.

Analysis: Limited institutional interest may indicate size constraints or visibility issues.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Unihealth Hospitals Ltd vs Hospital Peers

Peer Comparison - Hospital

Compare Unihealth Hospitals Ltd with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
65.8/100
720
₹1123.65
43.8
Average
21.46%
Excellent
24.48%
Excellent
0.2
Excellent
38.61%
Excellent
38.17%
Excellent
0.00%
62.1/100
8817
₹128448.55
61.5
Average
21.95%
Excellent
19.28%
Good
0.6
Good
66.81%
Excellent
19.03%
Excellent
0.22%
56.9/100
1014
₹107422.79
73.7
Average
14.33%
Average
13.43%
Average
0.3
Excellent
27.30%
Excellent
0.18%
56.8/100
917
₹73687.64
70.3
Average
11.08%
Average
12.83%
Average
0.3
Excellent
17.76%
Excellent
0.10%
37.2/100
818
₹71917.90
225.7
Average
9.70%
Poor
11.35%
Average
0.2
Excellent
21.31%
Excellent
-11.61%
Poor
0.61%
68.3/100
1803
₹41592.95
51.0
Average
19.74%
Good
14.53%
Average
1.1
Average
25.05%
Excellent
0.22%
59.9/100
1443
₹35993.93
64.7
Average
15.15%
Good
16.85%
Good
0.3
Excellent
0.04%
13.9/100
806
₹33947.05
166.0
Average
11.01%
Average
9.35%
Poor
1.4
Average
3.71%
Average
24.04%
Excellent
0.00%
48.5/100
503
₹15618.15
105.3
Average
6.84%
Poor
10.16%
Average
0.1
Excellent
0.00%
65.5/100
1459
₹15270.28
53.5
Average
17.86%
Good
18.10%
Good
0.0
Excellent
0.23%
60/100
318
₹9829.95
52.3
Average
13.41%
Average
15.25%
Good
0.3
Excellent
0.07%

Unihealth Hospitals Ltd PE Ratio History

Historical price-to-earnings ratio for UNIHEALTH — last 5 years

YearEPS (₹)Price (₹)P/E Ratio
FY 20234.99₹128.1025.7x

P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.

Unihealth Hospitals Ltd Quarterly Performance

Latest quarterly metrics for UNIHEALTH — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

17.06%

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

18.98%

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

38.17%

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

38.61%

Compounded annual net profit growth over 5 years

Unihealth Hospitals Ltd Technical Indicators

SMA 50, SMA 200, RSI and volume signals for UNIHEALTH — calculated from daily price history

50RSI 14
Neutral — RSI 50

Momentum is balanced — neither overbought nor oversold.

SMA 50
665
▲ Price above SMA 50 — Short-term bullish
SMA 200
419
▲ Price above SMA 200 — Long-term uptrend
30-Day Avg Volume
23K shares/day
Average daily traded volume over last 30 trading sessions

Technical indicators are for educational purposes only. Not investment advice.

Unihealth Hospitals Ltd Financial Statements

Annual income statement, balance sheet and cash flow for Unihealth Hospitals Ltd (UNIHEALTH) — sourced from NSE/BSE filings.

Financial Results & Statements

Latest quarterly, annual and period-wise financial data for Unihealth Hospitals Ltd

Loading latest quarterly results...

About UNIHEALTH (Unihealth Hospitals Ltd)

Unihealth Hospitals Ltd (UNIHEALTH) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Hospital sector with a curr...ent market capitalisation of ₹1.12K (Cr). Unihealth Hospitals Ltd has delivered a Return on Equity (ROE) of 21.46% and a ROCE of 24.48%. The debt-to-equity ratio stands at 0.24, reflecting the company's capital structure. Investors tracking UNIHEALTH share price can monitor key metrics including P/E ratio, promoter holding of 69.53%, and quarterly earnings growth.

Company Details

Symbol:UNIHEALTH
Industry:Hospital
Sector:Hospital
Website:N/A

UNIHEALTH Share Price: Frequently Asked Questions

What is the current share price of Unihealth Hospitals Ltd?

Unihealth Hospitals Ltd (UNIHEALTH) trades at ₹720.00 on NSE. Market cap ₹1.12K (Cr). Educational data only.

What is the P/E ratio of Unihealth Hospitals Ltd?

Unihealth Hospitals Ltd has a P/E of 43.83x vs industry average 48.79x.

What is the Bull Run score for Unihealth Hospitals Ltd?

Unihealth Hospitals Ltd has a Bull Run score of 65.8/100 based on 25+ financial parameters.

Does Unihealth Hospitals Ltd pay dividends?

Unihealth Hospitals Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Unihealth Hospitals Ltd?

Unihealth Hospitals Ltd has ROE of 21.46%. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Unihealth Hospitals Ltd?

Unihealth Hospitals Ltd has debt-to-equity of 0.24.

Is Unihealth Hospitals Ltd a good investment?

Bull Run gives Unihealth Hospitals Ltd a score of 65.8/100. This is not investment advice — consult a SEBI-registered advisor.